• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Ipsilateral Postoperative Radiotherapy, Bilateral Irradiation Have Comparative Survival Rates in Patients with SCC of Unknown Primary

by Linda Kossoff • May 19, 2021

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

What is the impact on survival of patients with squamous cell carcinoma of unknown primary who were treated with ipsilateral neck dissection and ipsilateral postoperative radiotherapy (PORT), and those who received PORT to both sides of the neck and the pharyngeal axis (BILAX)?

BOTTOM LINE

You Might Also Like

  • Discovery of the Unknown Primary Tumor Is Associated with Improved Disease-Specific Survival
  • Upfront Transoral Laser Microsurgery May Offer Survival Benefit Over Radiotherapy in Patients With Early-Stage Supraglottic Squamous Cell Carcinoma
  • Survival Rates Comparable in Children and Adults with Oral Tongue Squamous Cell Cancer
  • Younger Patients with Oral Tongue Squamous Cell Carcinoma Have Better Survival Rates
Explore This Issue
May 2021

There is no significant difference in overall survival (OS) and disease-free survival (DFS) rates between patients with squamous cell carcinoma of unknown primary who are treated with ipsilateral neck dissection and ipsilateral PORT and patients treated with BILAX.

BACKGROUND: The most common histology in cervical metastasis is squamous cell carcinoma. In 3% to 9% of head and neck squamous cell carcinoma (HNSCC), the primary tumor remains unidentified. New techniques help identify the primary site in head and neck carcinoma of unknown primary (HNCUP), but substantial heterogeneity exists regarding treatment and management.

STUDY DESIGN: Retrospective cohort study.

SETTING: Department of Otorhinolaryngology and Head and Neck Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.

SYNOPSIS: Researchers retrospectively analyzed 78 patients (49 males, 29 females, mean age 60.7 years) with squamous cell carcinoma who were diagnosed between Jan. 1, 2006, and Dec. 31, 2015, and who received PORT following ipsilateral neck dissection. Thirty-nine patients received ipsilateral PORT (IPSI group) and another 39 patients received BILAX (BILAX group). The endpoints of the study were three-year OS, three-year DFS, and overall late radiation toxicity. The median follow-up duration for all 78 patients was 54 months (5–153 months). During this period, 26 patients died. For the IPSI and BILAX groups, the three-year OS rates were 74.4% and 74.1%, respectively; the three-year DFS rates were 73.8% and 71.4%, respectively. However, there was a significantly lower total toxicity score (16% low/15% moderate/3% high) and rate of xerostomia (15 patients) for patients in the IPSI group as opposed to the BILAX group (4% low/26% moderate/7% high and 31 patients, respectively). Study limitations included that the treatment protocols used at the time of this cohort may have skewed survival rates in favor of ipsilateral PORT.

CITATION: Berzenji D, Monserez DA, Verduijn GM, et al. Treatment of head and neck carcinoma of unknown primary: Cracking a nut with a sledgehammer? Laryngoscope Investig Otolaryngol. 2021;6:211-218.

Filed Under: Head and Neck, Head and Neck, Literature Reviews, Practice Focus Tagged With: clinical outcomes, clinical research, mortality rateIssue: May 2021

You Might Also Like:

  • Discovery of the Unknown Primary Tumor Is Associated with Improved Disease-Specific Survival
  • Upfront Transoral Laser Microsurgery May Offer Survival Benefit Over Radiotherapy in Patients With Early-Stage Supraglottic Squamous Cell Carcinoma
  • Survival Rates Comparable in Children and Adults with Oral Tongue Squamous Cell Cancer
  • Younger Patients with Oral Tongue Squamous Cell Carcinoma Have Better Survival Rates

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • Excitement Around Gene Therapy for Hearing Restoration

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Keeping Watch for Skin Cancers on the Head and Neck

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939